Literature DB >> 2370565

Acute- and insidious-onset myelopathy of undetermined aetiology: contribution of paraclinical tests to the diagnosis of multiple sclerosis.

M Filippi1, V Martinelli, T Locatelli, S Medaglini, A Poggi, A Visciani, G Scotti, N Canal, G Comi.   

Abstract

Brain magnetic resonance imaging (MRI), multimodality evoked potentials (EPs) and cerebrospinal fluid examination were performed in 42 patients with myelopathy of undetermined aetiology in order to detect abnormalities usually related to multiple sclerosis (MS). Patients were divided into three groups: insidious-onset myelopathy with only motor signs (group A; 11 patients), with both motor and sensory signs (group B; 18 patients) and acute-onset myelopathy (group C; 13 patients). Multiple brain MRI lesions were found in 18 patients (2 of group A, 13 of group B and 3 of group C). Another 7 patients had a single white-matter lesion. Visual EPs were abnormal in 21 and brain-stem auditory EPs in 12 patients. Paraclinical tests supported the diagnosis of MS in 25 patients (60%) by showing subclinical brain abnormalities. Oligoclonal bands were found in 16 of these 25 patients. The findings strongly suggest a diagnosis of MS in the patients of group B.

Entities:  

Mesh:

Year:  1990        PMID: 2370565     DOI: 10.1007/bf00314590

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes.

Authors:  D H Miller; W I McDonald; L D Blumhardt; G H du Boulay; A M Halliday; G Johnson; B E Kendall; D P Kingsley; D G MacManus; I F Moseley
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

2.  Evaluation by MRI of paraparesis and tetraparesis of undiagnosed aetiology.

Authors:  E B Ringelstein; D Krieger; B Hünermann
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

3.  Comparison of magnetic resonance imaging with somatosensory testing in MS suspects.

Authors:  A Eisen; K Odusote; D Li; W Robertson; S Purvis; K Eisen; D Paty
Journal:  Muscle Nerve       Date:  1987-06       Impact factor: 3.217

4.  Correlation between multimodal evoked potentials and magnetic resonance imaging in multiple sclerosis.

Authors:  G Comi; V Martinelli; S Medaglini; T Locatelli; M Filippi; N Canal; F Triulzi; A Del Maschio
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

7.  Myelopathy patients studied with magnetic resonance for multiple sclerosis plaques.

Authors:  O Nilsson; E M Larsson; S Holtås
Journal:  Acta Neurol Scand       Date:  1987-10       Impact factor: 3.209

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

Authors:  I E Ormerod; D H Miller; W I McDonald; E P du Boulay; P Rudge; B E Kendall; I F Moseley; G Johnson; P S Tofts; A M Halliday
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

10.  Cranial magnetic resonance imaging in the evaluation of myelopathy of undetermined etiology.

Authors:  R M Miska; K W Pojunas; M P McQuillen
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

View more
  1 in total

1.  Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors.

Authors:  V Martinelli; G Comi; M Rovaris; M Filippi; B Colombo; T Locatelli; A Campi; M Rodegher; N Canal
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.